Check the status of reimbursement of modern cancer medicines in Poland
Oncoindex indicates the scope of reimbursement for modern cancer therapies.
A negative value on the scale from -100 to 0 demonstrates how far we are from European standards of treatment.
Reimbursement status
Total number of substances
recommended by ESMO:
Show the list of substances
Sorry, there was a problem downloading your data.
Oncoindex review history
Sorry, there was a problem downloading your data.